Related Experiment Videos
CFTR: more than just a chloride channel
1Division of Maternal and Child Health Sciences, Ninewells Hospital Medical School, Dundee, Scotland, UK. a.mehta@dundee.ac.uk
Pediatric Pulmonology
|December 2, 2004
Summary
This review explores the cystic fibrosis transmembrane conductance regulator (CFTR) protein's non-channel functions. It highlights CFTR's role in lipid metabolism and potential links to inflammation in cystic fibrosis.
Area of Science:
- Cell Biology
- Molecular Medicine
- Biochemistry
Background:
- Cystic fibrosis is primarily viewed as a channelopathy, but the cystic fibrosis transmembrane conductance regulator (CFTR) protein has other crucial functions.
- Newly synthesized CFTR protein must enter lipid vesicles for proper cellular trafficking, a process impaired in DeltaF508 CFTR, the most common mutation.
Purpose of the Study:
- To review the non-channel functions of CFTR.
- To explore the relationship between CFTR trafficking, lipid metabolism, and inflammatory processes in cystic fibrosis.
- To discuss the role of AMP-activated kinase in integrating CFTR-related lipid metabolism abnormalities.
Main Methods:
- Literature review focusing on CFTR protein function beyond ion channel activity.
- Analysis of CFTR's role in vesicular transport from the endoplasmic reticulum.
- Exploration of links between abnormal fatty acid turnover and inflammatory cascades in cystic fibrosis.
Main Results:
- Newly synthesized CFTR requires entry into lipid vesicles for proper function, which is reduced in DeltaF508 CFTR.
- Abnormal, rapid retrieval of CFTR from the apical membrane into a sub-apical compartment occurs in DeltaF508 CFTR.
- Emerging evidence suggests AMP-activated kinase near CFTR's C-terminus may integrate lipid metabolism abnormalities.
Conclusions:
- CFTR's role extends beyond ion transport, significantly impacting lipid metabolism and cellular trafficking.
- Dysfunctional CFTR trafficking in cystic fibrosis is linked to altered fatty acid metabolism and inflammation.
- Targeting CFTR-associated lipid metabolism pathways, potentially involving AMP-activated kinase, may offer new therapeutic avenues for cystic fibrosis.